{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:31:40Z","timestamp":1792114300109,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Chonnam National University Hospital Biomedical Research Institute","award":["BCRI19042"],"award-info":[{"award-number":["BCRI19042"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.rmed.2020.106209","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T09:35:04Z","timestamp":1604309704000},"page":"106209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance"],"prefix":"10.1016","volume":"175","author":[{"given":"Eun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Young Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmed.2020.106209_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12879-020-4810-9","article-title":"Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea","volume":"20","author":"Lee","year":"2020","journal-title":"BMC Infect. Dis."},{"issue":"5","key":"10.1016\/j.rmed.2020.106209_bib2","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.05.20073-en","article-title":"Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011","volume":"17","author":"Uldum","year":"2012","journal-title":"Euro Surveill. : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin"},{"issue":"11","key":"10.1016\/j.rmed.2020.106209_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00968-19","article-title":"Macrolide-resistant mycoplasma pneumoniae in the United States as determined from a national surveillance program","volume":"57","author":"Waites","year":"2019","journal-title":"J. Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.rmed.2020.106209_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3345\/kjp.2017.60.5.151","article-title":"Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children","volume":"60","author":"Lee","year":"2017","journal-title":"Korean J Pediatr"},{"issue":"2","key":"10.1016\/j.rmed.2020.106209_bib5","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/AAC.01806-13","article-title":"More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia","volume":"58","author":"Zhou","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rmed.2020.106209_bib6","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268819000839","article-title":"The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016","volume":"147","author":"Gao","year":"2019","journal-title":"Epidemiol. Infect."},{"issue":"8","key":"10.1016\/j.rmed.2020.106209_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.cmi.2016.05.028","article-title":"Increased rates of intensive care unit admission in patients with Mycoplasma pneumoniae: a retrospective study","volume":"22","author":"Khoury","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.rmed.2020.106209_bib8","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1038\/s41598-017-08861-7","article-title":"Mycoplasma pneumoniae-associated bronchiolitis obliterans following acute bronchiolitis","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.rmed.2020.106209_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/17476348.2019.1586537","article-title":"Diagnosing and managing bronchiolitis obliterans in children","volume":"13","author":"Kavaliunaite","year":"2019","journal-title":"Expet Rev. Respir. Med."},{"issue":"6","key":"10.1016\/j.rmed.2020.106209_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/thx.2005.044909","article-title":"Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis","volume":"61","author":"Colom","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2020.106209_bib11","doi-asserted-by":"crossref","first-page":"105921","DOI":"10.1016\/j.mimet.2020.105921","article-title":"Comparison of a novel chemiluminescence immunoassay with the passive agglutination method for the diagnosis of Mycoplasma pneumoniae infection in children","volume":"173","author":"He","year":"2020","journal-title":"J. Microbiol. Methods"},{"issue":"4","key":"10.1016\/j.rmed.2020.106209_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.prrv.2010.07.005","article-title":"Post infectious bronchiolitis obliterans in children","volume":"11","author":"Fischer","year":"2010","journal-title":"Paediatr. Respir. Rev."},{"issue":"6\u20137","key":"10.1016\/j.rmed.2020.106209_bib13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/00365540902942840","article-title":"Mycoplasma pneumoniae bronchiolitis in adults: clinicoradiologic features and clinical course","volume":"41","author":"Cha","year":"2009","journal-title":"Scand. J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.rmed.2020.106209_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/INF.0000000000002529","article-title":"Meta-analysis of the clinical efficacy and safety of high- and low-dose methylprednisolone in the treatment of children with severe mycoplasma pneumoniae pneumonia","volume":"39","author":"Sun","year":"2020","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"1","key":"10.1016\/j.rmed.2020.106209_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12890-019-0990-8","article-title":"Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials","volume":"19","author":"Kim","year":"2019","journal-title":"BMC Pulm. Med."},{"issue":"5","key":"10.1016\/j.rmed.2020.106209_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050726","article-title":"Early corticosteroid therapy for mycoplasma pneumoniae pneumonia irrespective of used antibiotics in children","volume":"8","author":"Yang","year":"2019","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.rmed.2020.106209_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173635","article-title":"Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"12","author":"Ishiguro","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.rmed.2020.106209_bib18","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","article-title":"Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment","volume":"7","author":"Pereyre","year":"2016","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.rmed.2020.106209_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/trstmh\/trv042","article-title":"Epidemiology of adenovirus respiratory infections among hospitalized children in Seremban, Malaysia","volume":"109","author":"Foong Ng","year":"2015","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"5","key":"10.1016\/j.rmed.2020.106209_bib20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ppul.20984","article-title":"Clinical features and risk factors for bronchiolitis obliterans and mortality","volume":"44","author":"Murtagh","year":"2009","journal-title":"Pediatr. Pulmonol."},{"issue":"1","key":"10.1016\/j.rmed.2020.106209_bib21","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1186\/s40064-016-3237-7","article-title":"Hypoxemia is an independent predictor of bronchiolitis obliterans following respiratory adenoviral infection in children","volume":"5","author":"Wu","year":"2016","journal-title":"SpringerPlus"},{"issue":"10","key":"10.1016\/j.rmed.2020.106209_bib22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ppul.20472","article-title":"Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up","volume":"41","author":"Castro-Rodriguez","year":"2006","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.rmed.2020.106209_bib23","first-page":"5852827","article-title":"Postinfectious bronchiolitis obliterans in children: diagnostic workup and therapeutic options: a workshop report","volume":"2020","author":"Jerkic","year":"2020","journal-title":"Canc. Res. J."},{"issue":"1","key":"10.1016\/j.rmed.2020.106209_bib24","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1186\/s12879-019-4426-0","article-title":"Impact and clinical profiles of Mycoplasma pneumoniae co-detection in childhood community-acquired pneumonia","volume":"19","author":"Zhao","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.rmed.2020.106209_bib25","article-title":"Severe Mycoplasma pneumoniae infections with prolonged fever in a child: delayed treatment is as important as macrolide resistance","author":"Sim","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"10","key":"10.1016\/j.rmed.2020.106209_bib26","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3201\/eid2310.170106","article-title":"Macrolide-resistant mycoplasma pneumoniae infection, Japan,","volume":"23","author":"Tanaka","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.rmed.2020.106209_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.24892","article-title":"Postinfectious bronchiolitis obliterans and asthma: a misdiagnosis or overlap?","author":"Chong-Silva","year":"2020","journal-title":"Pediatr. Pulmonol."},{"issue":"11","key":"10.1016\/j.rmed.2020.106209_bib28","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jiac.2015.07.009","article-title":"Utility of serum ferritin and lactate dehydrogenase as surrogate markers for steroid therapy for Mycoplasma pneumoniae pneumonia","volume":"21","author":"Kawamata","year":"2015","journal-title":"J. Infect. Chemother."},{"issue":"1","key":"10.1016\/j.rmed.2020.106209_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12931-019-1152-5","article-title":"Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study","volume":"20","author":"Choi","year":"2019","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.rmed.2020.106209_bib30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jiac.2014.01.001","article-title":"Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level","volume":"20","author":"Inamura","year":"2014","journal-title":"J. Infect. Chemother."},{"issue":"10","key":"10.1016\/j.rmed.2020.106209_bib31","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4187\/respcare.03920","article-title":"Lactate dehydrogenase as a biomarker for prediction of refractory mycoplasma pneumoniae pneumonia in children","volume":"60","author":"Lu","year":"2015","journal-title":"Respir. Care"},{"issue":"2","key":"10.1016\/j.rmed.2020.106209_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00005382-199904000-00003","article-title":"High-resolution computed tomography in pediatric patients with postinfectious bronchiolitis obliterans","volume":"14","author":"Zhang","year":"1999","journal-title":"J. Thorac. Imag."},{"issue":"5","key":"10.1016\/j.rmed.2020.106209_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098381","article-title":"Ventilation\/perfusion scintigraphy in children with post-infectious bronchiolitis obliterans: a pilot study","volume":"9","author":"Xie","year":"2014","journal-title":"PloS One"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120303498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120303498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:05:13Z","timestamp":1760616313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611120303498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":33,"alternative-id":["S0954611120303498"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2020.106209","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2020.106209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106209"}}